Our advisory board

The KarMac advisory board and our clinical partners comprise world-renowned leaders in cellular immunotherapy, oncology research, and biotech development. Their collective expertise spans across top-tier academic institutions and leading pharmaceutical companies.

With decades of experience guiding novel therapeutics from early laboratory discovery through complex clinical trials, our advisors provide critical strategic oversight. They play a vital role in ensuring our CAR-monocyte platform successfully transitions from a groundbreaking concept into a real-world, life-saving clinical application.